# A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD

> **NCT06003049** · PHASE2 · COMPLETED · sponsor: **RMW Testing** · enrollment: 40 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** OnabotulinumtoxinA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06003049
- **Lead sponsor:** RMW Testing
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-04-24
- **Final completion:** 2024-07-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003049, "A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06003049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*